Tech Company Inital Public Offerings
Gossamer Bio IPO
Based in San Diego, Gossamer Bio is now a public company.
Transaction Overview
Company Name
Announced On
2/8/2019
Transaction Type
IPO
Amount
$276,000,000
Proceeds Purpose
Per the firm's latest filing, it plans to use the net proceeds from the IPO as follows: approximately $70.0 million to fund the research and development of GB001, approximately $40.0 million to fund the research and development of GB002, approximately $35.0 million to fund the research and development of GB004, approximately $40.0 million to fund research and development of our other development programs; and the remainder for working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
846 Hal St.
San Diego, CA 92102
USA
San Diego, CA 92102
USA
Phone
Website
Email Address
Overview
Gossamer Bio (Nasdaq: GOSS) is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Faheem Hasnain
Chief Financial Officer
Bryan Giraudo
Chief Operating Officer
Sheila Gujrathi
VP - General Counsel
Christian Waage
VP - Human Resources
Deanna Weber
Browse more venture capital transactions:
Prev: 2/8/2019: prima venture capital transaction
Next: 2/8/2019: Rebag venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs